title: Leptin responsiveness in chronically decerebrate rats.
abstract: Peripheral infusions of physiological doses of leptin decrease body fat mass, but it is not known whether this results from direct effects on peripheral tissue or activation of central leptin receptors. In this study, we infused chronically decerebrate (CD) rats, in which the forebrain was surgically isolated from the caudal brainstem, with 60 microg leptin/d or PBS for 14 d from ip mini-osmotic pumps. The CD rats were tube fed an amount of food equivalent to the intake of ad libitum-fed intact controls or 75% of this amount to account for their reduced energy expenditure. Control rats fed ad libitum or tube fed 75, 100, or 125% of their ad libitum intake also were peripherally infused with leptin or PBS. CD rats had a lower serum testosterone, energy expenditure, and lean body mass compared with controls but had increased levels of adiponectin and leptin and were obese. Leptin increased body fat and decreased energy expenditure during the light period in 100%-fed CD rats, but not 75%-fed CD rats. Leptin decreased body fat of ad libitum- and 100%-fed but not 75%-fed or 125%-fed intact controls. Energy expenditure did not change in any control group. These results show that leptin can change body fat independent of a change in food intake or energy expenditure, that the forebrain normally prevents leptin from inhibiting energy expenditure through mechanisms initiated in the caudal brainstem or peripheral tissues, and that the leptin response in both intact and CD rats is determined by the energy status of the animal.
authors.affiliation: Department of Foods and Nutrition, Dawson Hall, University of Georgia, Athens, GA 30602, USA. Harrisrb@uga.edu
authors.forename: Ruth B S
authors.initials: RB
authors.lastname: Harris
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Bartness
authors.forename: Harvey J
authors.initials: HJ
authors.lastname: Grill
mesh_terms: D000273:Adipose Tissue / Q000187:drug effects / Q000473:pathology; D000818:Animals; D001823:Body Composition / Q000187:drug effects; D002908:Chronic Disease; D003655:Decerebrate State / Q000150:complications / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology*; D004435:Eating; D004734:Energy Metabolism; D007260:Infusion Pumps; D020738:Leptin / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D009765:Obesity / Q000209:etiology; D010101:Oxygen Consumption; D016548:Prosencephalon / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013739:Testosterone / Q000097:blood
chemical_list: D020738:Leptin; D013739:Testosterone